Importer of Controlled Substances Registration, 5478 [2019-02870]
Download as PDF
<![CDATA[
5478
Federal Register / Vol. 84, No. 35 / Thursday, February 21, 2019 / Notices
Controlled substance
Drug
code
Cocaine ....................
Codeine ....................
Dihydrocodeine .........
Oxycodone ...............
Hydromorphone ........
Diphenoxylate ...........
Ecgonine ...................
Hydrocodone ............
Meperidine ................
Methadone ................
Methadone intermediate.
Morphine ...................
Thebaine ...................
Opium tincture ..........
Oxymorphone ...........
Noroxymorphone ......
Alfentanil ...................
Remifentanil ..............
Sufentanil ..................
Tapentadol ................
Fentanyl ....................
Schedule
9041
9050
9120
9143
9150
9170
9180
9193
9230
9250
9254
II
II
II
II
II
II
II
II
II
II
II
9300
9333
9630
9652
9668
9737
9739
9740
9780
9801
II
II
II
II
II
II
II
II
II
II
below. No comments or objections were
submitted for this notice.
Company
Sigma Aldrich
Research.
FR docket
Published
83 FR 54613
October 30, 2018.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of this registrant to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed company.
In reference to drug codes 7360
(Marijuana), and 7370 (THC), the
company plans to bulk manufacture
these drugs as synthetic. No other
activities for these drug codes are
authorized for this registration.
Dated: January 29, 2019.
John J. Martin,
Assistant Administrator.
Dated: February 11, 2019.
John J. Martin,
Assistant Administrator.
Myoderm ......
83 FR 66751
December 27, 2018.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrant to import the applicable
basic class of schedule II controlled
substances is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated the
company’s maintenance of effective
controls against diversion by inspecting
and testing the company’s physical
security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule II controlled substances to the
above listed company.
Dated: February 11, 2019.
John J. Martin,
Assistant Administrator.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
[Docket No. DEA–392]
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Notice of registration.
The registrant listed below
has applied for and has been granted a
registration by the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of various classes of
schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION: The
company listed below applied to be
registered as a bulk manufacturer of
various basic classes of controlled
substances. Information on the previous
published notice are listed in the table
Company
Jkt 247001
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
The registrants listed below
have applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as importers of
schedule I or schedule II controlled
substances.
The
companies listed below applied to be
registered as importers of various basic
classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
SUPPLEMENTARY INFORMATION:
FR docket
Janssen Pharmaceuticals, Inc ..........................................
Lipomed ............................................................................
Akorn, Inc ..........................................................................
Cambridge Isotope Laboratories ......................................
GE Healthcare ..................................................................
Fisher Clinical Services, Inc .............................................
17:08 Feb 20, 2019
[Docket No. DEA–392]
SUMMARY:
The registrant listed below
has applied for and has been granted
registration by the Drug Enforcement
Administration (DEA) as an importer of
schedule II controlled substances.
SUPPLEMENTARY INFORMATION: The
company listed below applied to be
registered as an importer of a basic class
of controlled substance. Information on
the previously published notice is listed
in the table below. No comments or
objections were submitted and no
requests for hearing were submitted for
this notice.
SUMMARY:
Notice of registration.
SUMMARY:
amozie on DSK3GDR082PROD with NOTICES1
Published
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
VerDate Sep<11>2014
FR docket
[FR Doc. 2019–02870 Filed 2–20–19; 8:45 am]
[FR Doc. 2019–02869 Filed 2–20–19; 8:45 am]
[FR Doc. 2019–02882 Filed 2–20–19; 8:45 am]
ACTION:
Company
PO 00000
83
83
83
83
83
83
FR
FR
FR
FR
FR
FR
Frm 00075
58598
58601
60896
60897
60899
60900
Fmt 4703
Published
...................................................................
...................................................................
...................................................................
...................................................................
...................................................................
...................................................................
Sfmt 4703
E:\FR\FM\21FEN1.SGM
21FEN1
November
November
November
November
November
November
20,
20,
27,
27,
27,
27,
2018.
2018.
2018.
2018.
2018.
2018.
]]>Agencies
[Federal Register Volume 84, Number 35 (Thursday, February 21, 2019)]
[Notices]
[Page 5478]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02870]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The registrant listed below has applied for and has been
granted registration by the Drug Enforcement Administration (DEA) as an
importer of schedule II controlled substances.
SUPPLEMENTARY INFORMATION: The company listed below applied to be
registered as an importer of a basic class of controlled substance.
Information on the previously published notice is listed in the table
below. No comments or objections were submitted and no requests for
hearing were submitted for this notice.
------------------------------------------------------------------------
Company FR docket Published
------------------------------------------------------------------------
Myoderm........................ 83 FR 66751 December 27, 2018.
------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of the listed registrant to
import the applicable basic class of schedule II controlled substances
is consistent with the public interest and with United States
obligations under international treaties, conventions, or protocols in
effect on May 1, 1971. The DEA investigated the company's maintenance
of effective controls against diversion by inspecting and testing the
company's physical security systems, verifying the company's compliance
with state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule II controlled substances to the above listed
company.
Dated: February 11, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-02870 Filed 2-20-19; 8:45 am]
BILLING CODE 4410-09-P
